Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06063317 |
| Title | A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS) (OASIS) |
| Acronym | OASIS |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Imugene Limited |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| City of Hope | Duarte | California | 91010 | United States | Details | |
| Emory Winship Cancer Institute | Atlanta | Georgia | 30322 | United States | Details | |
| Northwestern | Chicago | Illinois | 60208 | United States | Details | |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198 | United States | Details | |
| Roswell Park Comprehensive Cancer Center | Buffalo | New York | 14203 | United States | Details | |
| University of Cincinnati | Cincinnati | Ohio | 45219 | United States | Details | |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15219 | United States | Details | |
| MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details |